We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · October 26, 2020

Impact of Chemoradiotherapy on the Immune-Related Tumor Microenvironment and Efficacy of Anti–PD-(L)1 Therapy for Recurrences After Chemoradiotherapy for Unresectable Locally Advanced NSCLC

European Journal of Cancer

 

Additional Info

European Journal of Cancer
Impact of Chemoradiotherapy on the Immune-Related Tumour Microenvironment and Efficacy of Anti-PD-(L)1 Therapy for Recurrences After Chemoradiotherapy in Patients With Unresectable Locally Advanced Non-Small Cell Lung Cancer
Eur. J. Cancer 2020 Oct 08;140(xx)28-36, M Shirasawa, T Yoshida, Y Matsumoto, Y Shinno, Y Okuma, Y Goto, H Horinouchi, N Yamamoto, SI Watanabe, Y Ohe, N Motoi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading